Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
Beta-adrenoblockers (ВАВ) are widely used in coronary heart disease (CHD) management. The choice of specific ВАВ and their place in optimal schemes for CHD treatment are discussed.
Saved in:
Main Authors: | I. A. Libov, Yu. N. Moiseeva, A. R. Gaynullina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1754 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01) -
Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01) -
Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01) -
Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01) -
Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)